Successful Treatment of Bacteremia Due to NDM-1-Producing Morganella morganii with Aztreonam and Ceftazidime-Avibactam Combination in a Pediatric Patient with Hematologic Malignancy

Antimicrob Agents Chemother. 2019 Jan 29;63(2):e02463-18. doi: 10.1128/AAC.02463-18. Print 2019 Feb.

Claire Amaris Hobson¹, Stéphane Bonacorsi^{1

2}, Mony Fahd³, André Baruchel³, Aurélie Cointe^{1

2}, Nora Poey⁴, Hervé Jacquier^{1

5}, Catherine Doit^{1

2}, Audrey Monjault², Olivier Tenaillon¹, André Birgy^{6

2}

¹ IAME, UMR 1137, INSERM, Université Paris Diderot, Sorbonne Paris Cité, AP-HP, Paris, France.
² Service de Microbiologie, Hôpital Robert Debré, AP-HP, Paris, France.
³ Service d'Immuno-Hématologie Pédiatrique, Hôpital Robert Debré, AP-HP, Paris, France.
⁴ Service de Pédiatrie Générale Hôpital Robert Debré, AP-HP, Paris, France.
⁵ Service de Microbiologie, Hôpital Lariboisière, AP-HP, Paris, France.
⁶ IAME, UMR 1137, INSERM, Université Paris Diderot, Sorbonne Paris Cité, AP-HP, Paris, France andre.birgy@aphp.fr.

No abstract available

Publication types